NCT02273453已完成1 期
A Randomised, Double-blind, Double-dummy, Placebo-controlled Cross-over Trial to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets (120 mg Valerian / 80 mg Lemon Balm)
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 54
- 主要终点
- Changes from baseline of the Pupillary Unrest Index (PUI) measured by pupillographic sleepiness test
研究概览
简要总结
Study to determine the presence of a hang-over effect in healthy volunteers the day after the administration of Songha® Night
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy male or female Caucasian subjects aged 20-60 years
- •Normal outcome in Pittsburgh Sleep Quality Index (PSQI), below mean +2 Standard Deviation (SDs)
- •No manifest sleep disorder diagnosed by polysomnography
- •Normal pupillary function
- •Willing and able to give written informed consent in accordance with Good Clinical Practice (GCP) and local legislation prior to participation in the study and able to perform the study during the full time period of 36 days
排除标准
- •Subjective sleep duration of less than 3 hours in the night before the test
- •Caffeine, nicotine or alcohol on the day (from midnight) of the test
- •Alcohol consumption on the evening before visits 3, 5 or 7
- •Eye-drops or other drugs, taken orally or intravenously, influencing pupil size or motility
- •Shift work
- •Drug and alcohol abuse
- •Use of psycho-active drugs during the past 30 days
- •Any treatment that might interfere with the evaluation of the test drug
- •Any drug known to interact with benzodiazepines and related drugs, e.g. antiepileptics, antihistaminics, muscle relaxant drugs, antihypertensive drugs, drugs inhibiting cytochrome P450
- •Any serious disorder that might interfere with his/her participation in this study and the evaluation of the efficacy or safety of the test drug (e.g. renal insufficiency, hepatic or metabolic dysfunction, cardiovascular disease, psychiatric disorder, myasthenia gravis, delirious state, etc.)
- •Known hypersensitivity to any of the ingredients of the study drugs
- •Pregnant or nursing women or inadequate birth control methods (this applies to female of childbearing potential only)
- •Participation in another trial within the past 30 days
研究组 & 干预措施
Songha® Night
Experimental
干预措施: Songha® Night (Drug)
Placebo + Oxazepam
Active Comparator
干预措施: Oxazepam (Drug)
Placebo + Oxazepam
Active Comparator
干预措施: Placebo (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Changes from baseline of the Pupillary Unrest Index (PUI) measured by pupillographic sleepiness test
时间窗: 08:00h, 09:30h, 11:00h at Day 7 of each treament period
次要结局
- Change in subjective sleepiness rated on a 7 point scale(up to day 36)
- Global Assessment of tolerability by investigator on 4-point scale(Day 36)
- Change of the Pupillary Unrest Index (PUI) measured by pupillographic sleepiness test(up to day 36)
- Change in subjective sleepiness measured on a visual analogue scale (VAS)(up to day 36)
- Change in sleep quality measured on a visual analogue scale (VAS)(up to day 36)
- Global Assessment of tolerability by patient on 4-point scale(Day 36)
- Number of subjects with adverse events(up to 36 days)
研究者
相似试验
Unknown
不适用
Effect of Two Alcohol-free Beers With Different Carbohydrates Composition on Lipids and Glucose MetabolismGlucose Metabolism Disorders (Including Diabetes Mellitus)Overweight and ObesityNCT03337828Instituto Aragones de Ciencias de la Salud44
已完成
不适用
Use of NAC in Alleviation of Hangover SymptomsHangover Symptoms, NACNCT02541422St. Luke's Hospital and Health Network, Pennsylvania62
招募中
2 期
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseSystemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)NCT06189495Changchun GeneScience Pharmaceutical Co., Ltd.30
已完成
不适用
Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of LahoreOverweight and ObesityNCT05451927Hafiza Aisha Sadiqa72
招募中
不适用
Het effect van fenretinide op insulinegevoeligheid.ObesityMetabolic syndrome XInsulin resistanceFatty liverNL-OMON25232Academic Medical Center (AMC)20